Charts Freenome, Inc.

Stocks

End-of-day quote Nasdaq Other stock markets 27/07/2026			5-day change	1st Jan Change
11.38 ^USD	+1.25%		-4.77%	-12.66%

28/07	Freenome, Inc. Announces FDA Approval of SimpleScreen CRC Blood-Based Screening Test and Abbott to Commercialize in the U.S	CI
27/07	FDA approves Freenome's blood test for colorectal cancer screening	RE

ProRealTime Chart